Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00545298 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers
A Phase 2 study, sponsored by Nitric BioTherapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT00545298 is a Phase 2 study that was terminated before completion, run by Nitric BioTherapeutics. The registered enrollment target is 4 participants.
The verdict
NCT00545298, a Phase 2 study, was terminated before completion, sponsored by Nitric BioTherapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study will test the safety and efficacy of nitric oxide gas in the treatment of venous leg ulcers
Interventions
- DRUG Nitric Oxide - same dose 6 wks
- DRUG Nitric Oxide modified treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00545298
The ClinicalTrials.gov registry entry for NCT00545298 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nitric BioTherapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nitric Oxide - same dose 6 wks is the first listed.
NCT00545298 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00545298 about?
NCT00545298 is a clinical study titled "Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers". This study will test the safety and efficacy of nitric oxide gas in the treatment of venous leg ulcers
What is the current status of trial NCT00545298?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2007-10. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00545298?
The interventions under investigation include: Nitric Oxide - same dose 6 wks (DRUG), Nitric Oxide modified treatment (DRUG).
Who is sponsoring clinical trial NCT00545298?
This trial is sponsored by Nitric BioTherapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.